CSS LLC’s Five Prime Therapeutics FPRX Stock Holding History
Bought
Maintained
Sold
CSS LLC's FPRX Position: Q2 2021 in Review
CSS LLC sold out of Five Prime Therapeutics (FPRX) in Q2 2021, closing a stake of 46,582 shares — an estimated $1.76M sold.
CSS LLC first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $1.76M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.
- CSS LLC reported no remaining Five Prime Therapeutics position as of Q2 2021 after selling out during the quarter.
- CSS LLC sold 46,582 Five Prime Therapeutics shares in Q2 2021, an estimated $1.76M.
- CSS LLC first reported a position in Five Prime Therapeutics in Q1 2021 and held it in 1 quarter.
- CSS LLC's Five Prime Therapeutics position peaked at $1.76M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Five Prime Therapeutics as of Q2 2021.
Based on CSS LLC's 13F filing for Q2 2021, filed 16 Aug 2021.